获利能力 Profitability (单位:美元)
| 指标 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 净资产收益率(ROE) | 44.48% | 70.73% | 76.13% | 73.16% | 126.47% | 135.79% | 67.55% | 106.10% |
| 总资产收益率(ROA) | 12.64% | 13.13% | 11.54% | 9.63% | 10.06% | 6.91% | 4.45% | 8.51% |
| 毛利率 | 82.73% | 81.35% | 75.77% | 75.16% | 75.66% | 70.02% | 61.53% | 67.25% |
| 净利率 | 35.35% | 33.57% | 28.57% | 22.68% | 24.89% | 23.83% | 12.24% | 20.98% |
| 每股收益(EPS) | 12.70 | 12.96 | 12.40 | 10.34 | 12.18 | 12.56 | 7.62 | 14.33 |
财务结构 Financial Structure
| 指标 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 现金占总资产比率 | 10.46% | 10.11% | 9.95% | 13.06% | 11.72% | 11.26% | 13.04% | 10.08% |
| 负债占总资产比率 | 81.18% | 83.80% | 85.05% | 89.05% | 94.38% | 93.59% | 93.60% | 90.44% |
经营能力 Operating Capability
| 指标 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 应收账款周转率(次) | 6.29 | 5.47 | 5.36 | 4.96 | 4.46 | 3.70 | 4.72 | 3.67 |
| 平均收现日数 | 58 天 | 67 天 | 68 天 | 74 天 | 82 天 | 99 天 | 77 天 | 99 天 |
| 固定资产周转率(次) | 0.2200 | 0.2219 | 0.2017 | 0.2134 | 0.2188 | 0.2208 | 0.2043 | 0.2251 |
| 总资产周转率 | 33.93% | 37.19% | 38.51% | 39.72% | 38.08% | 27.70% | 34.87% | 38.80% |
现金流量 Cash Flow (单位:亿美元)
| 指标 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 现金及现金等价物 | 69.45 | 60.37 | 62.66 | 79.89 | 76.29 | 109.44 | 119.73 | 91.29 |
| 净利润 | 83.94 | 78.42 | 72.64 | 58.93 | 65.52 | 67.17 | 40.90 | 77.11 |
| 经营活动现金流量 | 112.96 | 91.50 | 104.97 | 92.61 | 97.21 | 84.71 | 114.90 | 99.58 |
| 投资活动现金流量 | 143.39 | 57.09 | -54.01 | 7.33 | -60.44 | -262.04 | -10.46 | -19.43 |
| 筹资活动现金流量 | -224.90 | -157.67 | -48.67 | -82.71 | -40.37 | 210.48 | -94.15 | -108.59 |
| 净现金流量 | 31.45 | -9.08 | 2.29 | 17.23 | -3.60 | 33.15 | 10.29 | -28.44 |
医疗保健
- 近五年ROE对比
1
100.00%
PACS Group Inc
PACS
2
100.00%
ImmunityBio Inc
亏损年份
IBRX
3
100.00%
安进
AMGN
4
100.00%
奥洛兹美医疗
HALO
5
100.00%
Puma Biotechnology Inc
亏损年份
PBYI
6
100.00%
沃特世
WAT
7
100.00%
Picard Medical Inc
数据<5年
亏损年份
PMI
8
84.37%
IDEXX实验室
IDXX
9
79.94%
泰尼特保健
THC
10
74.93%
礼来
LLY
11
74.56%
诺和诺德
NVO
12
62.37%
BridgeBio Pharma Inc
亏损年份
BBIO
13
52.47%
硕腾
ZTS
14
50.94%
NRC Health
NRC
15
49.16%
Medpace Holdings Inc
MEDP
16
48.89%
葛兰素史克
GSK
17
32.44%
Harmony Biosciences Holdings In
HRMY
18
32.16%
Innoviva Inc
INVA
19
31.55%
强生
JNJ
20
30.84%
默沙东
MRK
21
30.27%
Chemed Corp
CHE
22
29.98%
InMode Ltd
INMD
23
28.48%
西佳科技
SIGA
24
27.65%
爱德华兹生命科学
EW
25
26.99%
诺华制药
NVS
26
25.87%
Catalyst Pharmaceuticals Inc
CPRX
27
25.81%
吉利德科学
GILD
28
24.45%
再生元制药
REGN
29
23.09%
德康医疗
DXCM
30
23.02%
瑞思迈
RMD